- Home
- EVMN vs PRME Comparison
EVMN vs PRME Comparison
Compare EVMN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVMN | PRME |
|---|---|---|
| Founded | 2020 | 2019 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.5M | 666.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | EVMN | PRME |
|---|---|---|
| Price | $22.10 | $2.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $43.88 | $7.56 |
| AVG Volume (30 Days) | 308.6K | ★ 2.2M |
| Earning Date | 06-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,632,000.00 |
| Revenue This Year | N/A | $7.06 |
| Revenue Next Year | N/A | $47.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 55.28 |
| 52 Week Low | $13.89 | $1.11 |
| 52 Week High | $33.20 | $6.94 |
Technical Indicators
Market Signals| Indicator | EVMN | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 41.98 | 33.53 |
| Support Level | $21.39 | N/A |
| Resistance Level | $23.08 | $3.97 |
| Average True Range (ATR) | 1.42 | 0.24 |
| MACD | -0.21 | -0.06 |
| Stochastic Oscillator | 25.45 | 16.94 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.